EUVIMEDEUVIMED entdecken
VergleichsstudieBeobachtungsstudie

Comparison of the effects of empagliflozin and sitagliptin, as add-on to metformin, on serum levels of asprosin and metabolic parameters in patients with type 2 diabetes mellitus

Seyed Saman Talebi iD, Shabnam Rezaie, Minoo Sadat Hajmiri iD, Maryam Zamanirafe, Akram Ranjbar, Heresh Moridi iD, Mahtabalsadat Mirjalili, Maryam Mehrpooya iD

Naunyn-Schmiedeberg's Archives of Pharmacology · 2024

DOI: 10.1007/s00210-024-03219-z ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2024. Verfasst von Seyed Saman Talebi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran. Hauptthemen laut MEDLINE: Glucosides, Diabetes Mellitus, Type 2, Sitagliptin Phosphate, Benzhydryl Compounds. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 71 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucosidesDiabetes Mellitus, Type 2Sitagliptin PhosphateBenzhydryl CompoundsMetforminHypoglycemic AgentsDrug Therapy, CombinationBlood GlucoseFibrillin-1HumansMaleMiddle AgedFemaleProspective StudiesInsulin ResistanceAgedGlycated HemoglobinPeptide FragmentsAdultLipidsAdipokines

Stichwörter der Autor:innen

AsprosinEmpagliflozinInsulin resistanceMetabolic parametersMetforminSitagliptin

Substanzen

GlucosidesSitagliptin PhosphateempagliflozinBenzhydryl CompoundsMetforminHypoglycemic AgentsBlood GlucoseFibrillin-1FBN1 protein, humanGlycated Hemoglobin

Autor:innen und Institutionen

  • Department of Internal Medicine, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
  • Department of Clinical Pharmacy, School of Pharmacy, Hamadan University of Medical Sciences, Shahid Fahmideh Ave, Hamadan, 6517838678, Iran.
  • Medical Faculty, Hamadan University of Medical Science, Hamadan, Iran.
  • Department of Pharmacology Toxicology, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran.
  • Department of Medical Laboratory Sciences, Faculty of Paramedical Sciences, Kurdistan University of Medical Sciences, Sanandaj, Iran.
  • Department of Clinical Pharmacy, School of Pharmacy, Yazd University of Medical Sciences, Yazd, Iran.

ORCID-Profile: Seyed Saman Talebi, Minoo Sadat Hajmiri, Heresh Moridi, Maryam Mehrpooya

Zitieren

APA

Talebi, S. S., Rezaie, S., Hajmiri, M. S., Zamanirafe, M., Ranjbar, A., Moridi, H., Mirjalili, M., & Mehrpooya, M. (2024). Comparison of the effects of empagliflozin and sitagliptin, as add-on to metformin, on serum levels of asprosin and metabolic parameters in patients with type 2 diabetes mellitus. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03219-z

Vancouver

Talebi SS, Rezaie S, Hajmiri MS, Zamanirafe M, Ranjbar A, Moridi H, et al. Comparison of the effects of empagliflozin and sitagliptin, as add-on to metformin, on serum levels of asprosin and metabolic parameters in patients with type 2 diabetes mellitus. Naunyn-Schmiedeberg's Archives of Pharmacology. 2024. doi:10.1007/s00210-024-03219-z

BibTeX
@article{Talebi2024,
  author = {Talebi, Seyed Saman and Rezaie, Shabnam and Hajmiri, Minoo Sadat and Zamanirafe, Maryam and Ranjbar, Akram and Moridi, Heresh and Mirjalili, Mahtabalsadat and Mehrpooya, Maryam},
  title = {Comparison of the effects of empagliflozin and sitagliptin, as add-on to metformin, on serum levels of asprosin and metabolic parameters in patients with type 2 diabetes mellitus},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2024},
  doi = {10.1007/s00210-024-03219-z}
}
Kostenlos starten →